Related Experiment Video
Updated: Jun 2, 2026

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
A human xenograft model for testing early events of epithelial neoplastic invasion
J McCandless1, A Cress, I Rabinovitz
1UNIV ARIZONA,ARIZONA CANC CTR,DEPT RADIAT ONCOL,TUCSON,AZ 85724. UNIV ARIZONA,DEPT MICROBIOL & IMMUNOL,TUCSON,AZ 85724. UNIV ARIZONA,DEPT PATHOL,TUCSON,AZ 85724. UNIV ARIZONA,ARIZONA RES LABS,DIV BIOTECHNOL,TUCSON,AZ 85724. HARVARD UNIV,SCH MED,DIV GASTROENTEROL,BOSTON,MA 02115. BETH ISRAEL HOSP,DIV GASTROENTEROL,BOSTON,MA 02115.
Abstract:
We report on a model of human prostate tumor cell invasion using the SCID (severe combined immunodeficient) mouse diaphragm. Tumor cells were injected into SCID mice intraperitoneally and the diaphragms harvested three to five weeks later. Electron microscopy showed tumor cell penetration of the mesothelial cell layer and adhesion to the underlying basement membrane on the inferior surface of the mouse diaphragm, where colonies developed. Immunohistochemistry showed invasion by tumor cells through the basement membrane into the muscle of the diaphragm, presence of human tumor cells among the muscle cells and the presence of selected proteins on the invasion front of the tumor cells. Digital image analysis enabled quantitative comparison of events in the metastatic cascade by variants of the tumor cell line and evaluation of the effectiveness of a putative tumor inhibitor. Results suggest that the SCID mouse diaphragm model is a convenient, effective, easily oriented and reproducible in vivo model of the early events associated with human prostate tumor cell invasion.
More Related Videos
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
05:11Construction of An Orthotopic Xenograft Model of Non-Small Cell Lung Cancer Mimicking Disease Progression and Predicting Drug Activities
Published on: May 10, 2024